With the appearance of this new disease, in 2019/2020, the pharmaceutical industry is strongly affected.
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market.
The abuse and misuse of antibiotics in animals and humans are contributing to the increased threat posed by antimicrobial resistance.
What can be done with the medicines that we no longer use in a way that does not affect our health or the environment?
Sergio Lucero: “Amarin differentiates itself by respecting all the rules and being flexible in dealing”
What makes it possible for Amarin, a small player, to compete in the big leagues of the transdermal market? Here are the reasons in the voice of our Director & CEO, Sergio Lucero.
Cleaning validation is a procedure of establishing evidence that cleaning processes for manufacturing equipment prevent product contamination
Contamination of drugs raises concern because of the risks that constant exposure to drugs in the environment and in humans can bring.
A review of the evolution of the transdermal market in the voice of Dr. Francisco Stefano, our director. Challenges of science and passion as protagonists.
In recent years, laboratories have been investigating new alternatives to eliminate or avoid animal testing of cosmetic and medical products.
The correct adhesion of a transdermal patch to skin throughout the established time of use is key to guarantee the effective administration of the dose declared in the prescribing information.